All Stories

  1. Determining EDC exposure: direct analytical methods are essential for accurate analysis of human biospecimens

    Article • Journal of the Endocrine Society, March 2026, Endocrine Society

    Deborah French

  2. Cannabis positivity rates in 17 emergency departments across the United States with varying degrees of marijuana legalization

    Article • Journal of Toxicology Clinical Toxicology, April 2023, Taylor & Francis

    Deborah French

  3. Clinical utility of laboratory developed mass spectrometry assays for steroid hormone testing

    Article • Journal of Mass Spectrometry and Advances in the Clinical Lab, April 2023, Elsevier

    Deborah French

  4. Liquid chromatography–tandem mass spectrometry for clinical diagnostics

    Article • Nature Reviews Methods Primers, December 2022, Springer Science + Business Media

    Deborah French

  5. Reduced Immune Response and Neutralizing Antibody Activity to the SARS-CoV-2 Vaccination in Patients with a History of Solid Organ Transplant

    Article • Laboratory Medicine, June 2022, Oxford University Press (OUP)

    Deborah French

  6. Is the Best Drug Test the Enemy of the Good STAT Toxicology Screen?

    Article • The Journal of Applied Laboratory Medicine, January 2022, Oxford University Press (OUP)

    Deborah French

  7. Drug testing in the era of new psychoactive substances

    Article • January 2022, Elsevier

    Deborah French

  8. The effect of the Covid-19 shutdown on glycemic testing and control

    Article • Clinica Chimica Acta, August 2021, Elsevier

    Deborah French

  9. Side-Effects of COVID-19 on Patient Care: An INR Story

    Article • The Journal of Applied Laboratory Medicine, March 2021, Oxford University Press (OUP)

    Deborah French

  10. Adding Value to Clinical Toxicology Testing

    Article • The Journal of Applied Laboratory Medicine, October 2020, Oxford University Press (OUP)

    Deborah French

  11. The 2018 AACC/SYCL PhD Clinical Chemist Compensation Survey

    Article • The Journal of Applied Laboratory Medicine, March 2020, Oxford University Press (OUP)

    Deborah French

  12. Development and validation of a LC-MS/MS assay for quantification of serum estradiol using calibrators with values assigned by the CDC reference measurement procedure

    Article • Clinica Chimica Acta, May 2019, Elsevier

    Deborah French

  13. Serum 25-Hydroxyvitamin D Concentrations from Patient Groups at High Risk for Deficiency

    Article • The Journal of Applied Laboratory Medicine, April 2019, AACC

    Deborah French

  14. Commentary

    Article • Clinical Chemistry, January 2019, AACC

    Deborah French

  15. Comparison of four clinically validated testosterone LC-MS/MS assays: Harmonization is an attainable goal

    Article • Clinical Mass Spectrometry, January 2019, Elsevier

    Deborah French

  16. A practical first step using needs assessment and a survey approach to implementing a clinical pharmacogenomics consult service

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, December 2018, Wiley

    Deborah French

  17. The (Sun)Light and Dark of 25-Hydroxyvitamin D Testing

    Article • The Journal of Applied Laboratory Medicine, June 2018, AACC

    Deborah French

  18. Quantification of Serum Voriconazole, Isavuconazole, and Posaconazole by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)

    Article • Current Protocols in Toxicology, April 2018, Wiley

    Deborah French

  19. A Case of Opioid Overdose? Or Is It?

    Article • The Journal of Applied Laboratory Medicine, October 2017, AACC

    Deborah French

  20. Advances in Clinical Mass Spectrometry

    Article • January 2017, Elsevier

    Deborah French

  21. Steroid hormones

    Article • January 2017, Elsevier

    Deborah French

  22. Advances in bioanalytical techniques to measure steroid hormones in serum

    Article • Bioanalysis, June 2016, Future Science

    Deborah French

  23. Population Pharmacokinetics of Busulfan in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplant

    Article • Therapeutic Drug Monitoring, April 2015, Wolters Kluwer Health

    Deborah French

  24. Development and validation of a liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay to quantify serum voriconazole

    Article • Journal of Chromatography B, April 2015, Elsevier

    Deborah French

  25. Genetic Data in Health Care: From Data to Information

    Article • Clinical Chemistry, January 2015, Oxford University Press (OUP)

    Deborah French

  26. Development and Validation of a Liquid Chromatography–Tandem Mass Spectrometry Assay to Quantify Plasma Busulfan

    Article • Therapeutic Drug Monitoring, April 2014, Wolters Kluwer Health

    Deborah French

  27. Interpreting Laboratory Results in Transgender Patients on Hormone Therapy

    Article • The American Journal of Medicine, February 2014, Elsevier

    Deborah French

  28. The challenges of LC–MS/MS analysis of opiates and opioids in urine

    Article • Bioanalysis, November 2013, Future Science

    Deborah French

  29. Direct total and free testosterone measurement by liquid chromatography tandem mass spectrometry across two different platforms

    Article • Clinical Biochemistry, May 2013, Elsevier

    Deborah French

  30. Implementation of liquid chromatography/mass spectrometry into the clinical laboratory

    Article • Clinica Chimica Acta, May 2013, Elsevier

    Deborah French

  31. The successful implementation of a licensed data management interface between a Sunquest® laboratory information system and an AB SCIEXTM mass spectrometer

    Article • Journal of Pathology Informatics, January 2013, Elsevier

    Deborah French

  32. Development and validation of a serum total testosterone liquid chromatography–tandem mass spectrometry (LC–MS/MS) assay calibrated to NIST SRM 971

    Article • Clinica Chimica Acta, January 2013, Elsevier

    Deborah French

  33. In Reply

    Article • Anesthesiology, September 2012, Wolters Kluwer Health

    Deborah French

  34. Role of liquid chromatography–high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology

    Article • Journal of Toxicology Clinical Toxicology, August 2012, Taylor & Francis

    Deborah French

  35. A Mixed (Long- and Medium-chain) Triglyceride Lipid Emulsion Extracts Local Anesthetic from Human Serum In Vitro  More Effectively than a Long-chain Emulsion

    Article • Anesthesiology, February 2012, Wolters Kluwer Health

    Deborah French

  36. Hydrophilic interaction LC–MS/MS analysis of opioids in urine: significance of glucuronide metabolites

    Article • Bioanalysis, December 2011, Future Science

    Deborah French

  37. Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxicological emergencies

    Article • Journal of Toxicology Clinical Toxicology, October 2011, Taylor & Francis

    Deborah French

  38. PharmGKB summary

    Article • Pharmacogenetics and Genomics, October 2011, Wolters Kluwer Health

    Deborah French

  39. KRAS mutation detection in colorectal cancer by a commercially available gene chip array compares well with Sanger sequencing

    Article • Clinica Chimica Acta, August 2011, Elsevier

    Deborah French

  40. Serum verapamil concentrations before and after Intralipid® therapy during treatment of an overdose

    Article • Journal of Toxicology Clinical Toxicology, April 2011, Taylor & Francis

    Deborah French

  41. A case of a rapid drop in lactate

    Article • The American Journal of Emergency Medicine, March 2011, Elsevier

    Deborah French

  42. Vitamin D status of county hospital patients assessed by the DiaSorin LIAISON® 25-hydroxyvitamin D assay

    Article • Clinica Chimica Acta, January 2011, Elsevier

    Deborah French

  43. Choosing the Right Benzodiazepine Assay: Impact on Clinical Decision Making

    Article • Laboratory Medicine, April 2010, Oxford University Press (OUP)

    Deborah French

  44. Lack of  -Hydroxybutyrate Prevalence Among An Urban Emergency Department Population

    Article • Journal of Analytical Toxicology, March 2010, Oxford University Press (OUP)

    Deborah French

  45. Germline genomic variants associated with childhood acute lymphoblastic leukemia

    Article • Nature Genetics, August 2009, Springer Science + Business Media

    Deborah French

  46. Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemia

    Article • Blood, May 2009, American Society of Hematology

    Deborah French

  47. Genome-wide Interrogation of Germline Genetic Variation Associated With Treatment Response in Childhood Acute Lymphoblastic Leukemia

    Article • JAMA, January 2009, American Medical Association (AMA)

    Deborah French

  48. Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia

    Article • Clinical Pharmacology & Therapeutics, August 2008, Wiley

    Deborah French

  49. Concordant Gene Expression in Leukemia Cells and Normal Leukocytes Is Associated with Germline cis-SNPs

    Article • PLOS One, May 2008, PLOS

    Deborah French

  50. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group

    Article • Blood, May 2008, American Society of Hematology

    Deborah French

  51. Ancestry and pharmacogenetics of antileukemic drug toxicity

    Article • Blood, January 2007, American Society of Hematology

    Deborah French

  52. Genetic Studies of a Cluster of Acute Lymphoblastic Leukemia Cases in Churchill County, Nevada

    Article • Environmental Health Perspectives, November 2006, Environmental Health Perspectives

    Glen Satten, Deborah French

  53. Genome-wide approach to identify risk factors for therapy-related myeloid leukemia

    Article • Leukemia, December 2005, Springer Science + Business Media

    Deborah French

  54. Global gene expression as a function of germline genetic variation

    Article • Human Molecular Genetics, April 2005, Oxford University Press (OUP)

    Deborah French

  55. Gene Expression Profiles Distinguish Children Who Develop Therapy-Related Myeloid Leukemia.

    Article • Blood, November 2004, American Society of Hematology

    Deborah French

  56. Global Gene Expression in Leukemic Blasts as a Function of Germline Genetic Variation.

    Article • Blood, November 2004, American Society of Hematology

    Deborah French

  57. A preliminary evaluation of the functional significance of alpha-1-acid glycoprotein glycosylation on wound healing

    Article • Biomedical Chromatography, January 2002, Wiley

    Deborah French